PTSD Mobile App for Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist cancer survivors with PTSD (posttraumatic stress disorder) using a mobile app called the Cancer Distress Coach (CaDC). The app provides tools based on cognitive behavioral therapy (CBT) to help manage stress. Participants will join one of several groups to receive either the app, the app with coaching (CaDC + mCoaching), regular therapy sessions, or standard care. The trial seeks cancer survivors who underwent a stem cell transplant 1-5 years ago and are experiencing significant PTSD symptoms. As an unphased trial, this study offers participants a unique chance to contribute to innovative research that could enhance PTSD management for cancer survivors.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this mobile app is safe for cancer survivors?
Research has shown that mobile apps using cognitive behavioral therapy (CBT) methods, such as the Cancer Distress Coach (CaDC) app, are generally safe and well-liked. In a small study, 89.7% of cancer survivors reported being at least moderately satisfied with a similar app for managing PTSD. This indicates the app is usually well-tolerated, with no major safety issues reported.
Specific safety data for using the CaDC app with mCoaching (weekly support from a clinician) is not available. However, both app-based therapies and clinician support are common in mental health care and are generally considered safe.
For the mCBT (mobile cognitive behavioral therapy) option, studies have shown it effectively reduces PTSD symptoms compared to no treatment. No major safety concerns have been reported, suggesting it is well-tolerated.
Overall, these digital and therapeutic options appear safe based on past research, but discussing any concerns with a healthcare provider is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about the Cancer Distress Coach (CaDC) app because it offers a unique, tech-driven approach to managing PTSD in cancer survivors. Unlike traditional therapy, which typically involves in-person sessions, the CaDC app provides immediate, on-the-go support using cognitive behavioral therapy (CBT) principles. This app empowers users with tools to manage stress at their own pace, which could be more convenient and accessible than standard therapy options. Additionally, the option to combine the app with weekly clinician support (in the CaDC and mCoaching arm) provides a blend of digital and human interaction, potentially enhancing the effectiveness of traditional therapy methods.
What evidence suggests that this trial's treatments could be effective for PTSD in cancer survivors?
Research shows that the Cancer Distress Coach (CaDC) app helps lower PTSD symptoms in cancer survivors. In a small study, 81% of users reported a significant drop in PTSD symptoms just four weeks after starting. Users also noted that the app improved their understanding of PTSD. In this trial, one group will receive the CaDC app alone, while another group will receive the CaDC app with additional coaching. Early results suggest that this combination may offer even more benefits for those needing extra support. Meanwhile, participants in a separate group will receive mobile cognitive behavioral therapy (mCBT), which has also proven effective in reducing PTSD symptoms. Specifically, participants using mCBT reported noticeable improvements in their condition after treatment.16789
Who Is on the Research Team?
Sophia K Smith, PhD, MSW
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for cancer survivors who've had a stem cell transplant 1-5 years ago and are showing signs of PTSD but haven't received CBT for it. They must be able to use a smart device, read/write English, have their oncologist's approval, and not be severely psychologically impaired.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants are randomized to a mobile app or usual care. An assessment will be made after 4 weeks.
Intensive Treatment
Based on the 4-week assessment, more intensive treatment may be added.
Follow-up
Participants are monitored for changes in distress, anxiety, self-efficacy, PTSD symptoms, depression, and quality of life.
What Are the Treatments Tested in This Trial?
Interventions
- CaDC + mCoaching
- Cancer Distress Coach (CaDC) App
- mCBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor